Sugar continues to generate headlines on both sides of the Atlantic. Here we present an analysis of recent events as part of our panel, "The Other Global Food Crisis," held this week at the World Economic Forum annual meeting.

Partner, Health & Life Sciences, Oliver Wyman

Dr. Charles Alessi, a Senior Advisor to Public Health England, says recent research calls for a bold whole-systems approach to reducing sugar consumption.

Senior Advisor, Public Health England

Individual sugar consumption is rising fastest in low- and middle-income nations, prompting governments around the globe to adopt a variety of regulations, food taxes, public-awareness campaigns, and advertising restrictions.

Partner, Health & Life Sciences, Oliver Wyman

Duke Royalty Limited, a Guernsey-based public diversified royalty company, and Oliver Wyman announced this week a financing collaboration in the rapidly developing pharmaceutical and healthcare-related royalty market.

Partner, Health & Life Sciences, Oliver Wyman

This week in Guinea, reports Tim Irwin in UNICEF Connect, aid workers have been responding to Ebola by addressing rumors and resistance. The disease continues to present challenges around the globe.

Insights in your inbox

Subscribe

Dr. Jeremy Lim, who heads Oliver Wyman's Health & Life Sciences Asia Pacific team, spoke earlier today at the Health, Business and Society Roundtable organized by ESSEC's Institute of Health Economics and Management Asia-Pacific. The roundtable event was held on the new Singapore campus of the France-based ESSEC Business School and focused on "Harnessing innovation for unmet needs in healthcare in Asia."

International healthcare experts gathered in London earlier today to share on-the-ground experiences of leading care model transformation. The International Care Models Conference was facilitated by Oliver Wyman in association with the UK’s Integrated Care Pioneer Programme, which develops innovative ways to coordinate care around people’s needs.

Oliver Wyman Partner Suresh Kumar, former US Assistant Secretary of Commerce, spoke last week at the Institute of Medicine of the National Academies in Washington, DC, as part of the two-day workshop "Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases."

Oliver Wyman alum & Executive Vice President at Sanofi

Oliver Wyman’s Health & Life Sciences Singapore-based team, led by Jeremy Lim, offers the following dispatch from the Asia Pacific Rim. They explain why it’s up to enterprising industry players and disrupters from the private sector to initiate new ways of providing and financing care to reach the masses in these huge, relatively unexplored markets:

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

An international panel of experts shared perspectives at the 2015 World Economic Forum annual meeting on what the world has learned from Africa’s Ebola epidemic.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More